Understanding prostate cancer risk in the use of 5-alpha reductase inhibitors

Authors

Kaiying Wang and Edmund Chiong

Published Date

Updated March 2025 (first published September 2017)

DOI

https://doi.org/10.18591/BJUIK.0006.v2

Access E-Learning

Cookie preferences

This site makes use of cookies to help improve our understanding of how you use the site. This information does not directly identify you, but because we respect your right to privacy, you can choose not to allow some types of cookies.